Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
- Status
- RECRUITING
- Phase
- N/A
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
- Status
- RECRUITING
- Phase
- PHASE2
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
- Status
- RECRUITING
- Phase
- N/A
Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy
- Status
- COMPLETED
- Phase
- N/A
A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
64Cu-LLP2A for Imaging Hematologic Malignancies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Epco, Zanu, Ritux for R/R FL or MZL
- Status
- RECRUITING
- Phase
- PHASE2
Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Emapalumab Prevention of CAR-T Cell Associated Toxicities
- Status
- RECRUITING
- Phase
- PHASE2
Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SynKIR-310 for Relapsed/Refractory B-NHL
- Status
- RECRUITING
- Phase
- PHASE1
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1